DrugsControl Media Services
DrugsControl.org

News Detail

Zydus Lifesciences received second Form 483 reprimand from US FDA (07-05-2024)

Maryland, 7 May 2024: Zydus Lifesciences recently received its second Form 483 reprimand from the FDA within the span of one month. In the second write-up, the regulatory agency flagged issues ranging from unqualified employees performing sample collections to improper evaluation......
View Details

Source : Fierce Pharma
Zydus Form 483 FDA inspection Fierce Pharma Homepage Manufacturing

Related News